Show simple item record

dc.creatorVeljković, Veljko
dc.creatorMetlaš, Radmila
dc.date.accessioned2018-03-01T19:31:08Z
dc.date.available2018-03-01T19:31:08Z
dc.date.issued2004
dc.identifier.issn0883-0185 (print)
dc.identifier.urihttp://vinar.vin.bg.ac.rs/handle/123456789/2807
dc.description.abstractIn sera of HIV-infected individuals natural antibodies recognizing nonimmunogenic C-terminal domain of the second conserved region of HIV-1 gp120 and the vasoactive intestinal peptide (VIP) were identified. It has been demonstrated that these antibodies are significantly more prevalent in asymptomatic carriers than in AIDS patients and that their titer strongly correlates with disease progression. These findings point out the VIP/C2-reactive natural antibodies as an important agent for immunotherapy of HIV disease.en
dc.rightsrestrictedAccessen
dc.sourceInternational Reviews of Immunologyen
dc.subjectgp120en
dc.subjectVIPen
dc.subjectnatural antibodiesen
dc.subjectimmunotherapyen
dc.titleApplication of VIP/NTM-reactive natural antibodies in therapy of HIV diseaseen
dc.typereviewen
dcterms.abstractВељковић Вељко; Метлас Радмила;
dc.citation.volume23
dc.citation.issue5-6
dc.citation.spage437
dc.citation.epage445
dc.identifier.wos000223983900006
dc.identifier.doi10.1080/08830180490432820
dc.identifier.pmid15370275
dc.identifier.scopus2-s2.0-4644247611


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record